Weitere Formate
Autorenfreundlich Bücher kaufen?!
Beschreibung
Introduction to Fragment-Based Drug Discovery, by Daniel A. Erlanson
Fragment Screening Using X-Ray Crystallography, by Thomas G. Davies and Ian J. Tickle
Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening, by Stephen Roughley, Lisa Wright, Paul Brough, Andrew Massey and Roderick E. Hubbard
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors, by Daniel F. Wyss, Yu-Sen Wang, Hugh L. Eaton, Corey Strickland, Johannes H. Voigt, Zhaoning Zhu and Andrew W. Stamford
Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery, by Michael Hennig, Armin Ruf and Walter Huber
Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery, by Eugene Valkov, Tim Sharpe, May Marsh, Sandra Greive and Marko Hyvönen
Fragment Screening and HIV Therapeutics, by Joseph D. Bauman, Disha Patel and Eddy Arnold
Fragment-Based Approaches and Computer-Aided Drug Discovery, by Didier Rognan
Details
| Verlag | Springer Berlin |
| Ersterscheinung | 22. Februar 2014 |
| Maße | 23.5 cm x 15.5 cm |
| Gewicht | 371 Gramm |
| Format | Softcover |
| ISBN-13 | 9783642446351 |
| Auflage | 2012 |
| Seiten | 228 |
Schlagwörter
Herstellerinformationen
Bekannt durch
